We encourage you to reach out to us for more information and to discuss whether this formulation might be right for you or your patients
Additionally, PC1/3 is expressed in -cells but at lower levels than PC2, and the ratio of GLP-1 to glucagon expressed in islet cells has been shown to be increased during the progression of diabetes (OMalley et al., 2014)
Both formats are stimulant-free and pair well with pre-workout stacks, making them suitable for any time of day
GLOW is a 70mg three-component blend (GHK-Cu + BPC-157 + TB-500)
Pfizer terminated lotiglipron in October 2023 due to dose-dependent liver enzyme elevations, and subsequently discontinued danuglipron in April 2025 after a single case of potential drug-induced liver injury was identified in a dose-optimization study
The 3 mg strength is often used at the start, while 7 mg or 14 mg may be used later depending on clinical direction